Classification of localized untreated prostate cancer based on 791 men treated only with radical prostatectomy: Common ground for therapeutic trials and TNM subgroups

Journal of Urology

Volumn 159, Issue 6, 1998, Pages 2009-2012

  Stamey, Thomas A ^a   Sözen, Tevfik S ^a   Yemoto, Cheryl M ^a   McNeal, John E ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Prostatectomy; Prostatic neoplasms

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER STAGING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; TREATMENT FAILURE;

EID: 0345129979     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63229-4     Document Type: Article

References (18)

1. Beahrs, O. H., Henson, D. E., Hutter, R. V. P. and Kennedy, B. J.: Manual for Staging Cancer, 4th ed. Philadelphia: J.B. Lippincott Co., 180, 1992.
2. Jewett, H. J.: Radical perineal prostatectomy for palpable, clinically localized, nonobstructive cancer: experience at the Johns Hopkins Hospital 1909-1963. J. Urol., 124: 492, 1980.
3. Bagshaw, M. A., Cox, R. S. and Ray, G. R.: Status of radiation treatment of prostate cancer at Stanford University. Natl. Cancer Inst. Monogr., 7: 47, 1988.
4. Ohori, M., Wheeler, T. M. and Scardino, P. T.: The New American Joint Committee on Cancer and International Union Against Cancer TNM classification of prostate cancer: clinicopathologic correlations. Cancer, 74: 104, 1994.
5. 2) for volume and grade of total cancer in the prostate. J. Urol., 147: 858, 1992.
6. Epstein, J. I., Oesterling, J. E. and Walsh, P. C.: The volume and anatomical location of residual tumor in radical prostatectomy specimens removed for stage A1 prostate cancer. J. Urol., 139: 975, 1988.
7. Christensen, W. N., Partin, A. W., Walsh, P. C. and Epstein, J. I.: Pathologic findings in clinical stage A2 prostate cancer: relation of tumor volume, grade, and location to pathologic stage. Cancer, 65: 1021, 1990.
8. Greene, D. R., Egawa, S., Neerhut, G., Flanagan, W., Wheeler, T. M. and Scardino, P. T.: The distribution of residual cancer in radical prostatectomy specimens in stage A prostate cancer. J. Urol., 145: 324, 1991.
9. Zietman, A. L., Coen, J. J., Dallow, K. C. and Shipley, W. U.: The treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome. Int. J. Rad. Oncol. Biol. Phys., 32: 287, 1995.
10. Stamey, T. A.: Some concerns about prostate cancer location, Gleason grade and postradiation doubling times. Int. J. Rad. Oncol. Biol. Phys., 33: 967, 1995.
11. McNeal, J. E., Redwine, E. A., Freiha, F. S. and Stamey, T. A.: Zonal distribution of prostatic adenocarcinoma: correlation with histologic pattern and direction of spread. Amer. J. Surg. Path., 12: 897, 1988.
12. Erbersdobler, A., Gürses, N., Hammerer, P., Huland, H. and Henke, R.-P.: Chromosomal aneusomies in transition zone carcinomas of the prostate. J. Urol., part 2. 157: 26, abstract 101, 1997.
13. Stamey, T. A., McNeal, J. E., Yemoto, C. M., Sigal, B. M. and Johnstone, I. M.: Gleason sums of 7 lose valuable prognostic information in comparison to estimates of % grade 4 and 5 cancer. J. Urol., part 2, 157: 204, abstract 794; 1997.
14. Prestigiacomo, A. F. and Stamey, T. A.: A comparison of 4 ultra-sensitive prostate specific antigen assays for early detection of residual cancer after radical prostatectomy. J. Urol., 152: 1515, 1994.
15. Noldus, J., McNeal, J. E. and Stamey, T. A.: Prostate specific antigen (PSA) levels per gram (gm) of cancer volume determined by a monoclonal assay. J. Urol., part 2, 155: 418, abstract 431, 1996.
16. Stamey, T. A., Dietrick, D. D. and Muta, M. I.: Large, organ confined, impalpable transition zone prostate cancer: association with metastatic levels of prostate specific antigen. J. Urol., 149: 510, 1993.
17. Elgamal, A.-A. A., Van Poppel, H. P., Van de Voorde, W. M., Van Dorpe, J. A., Oyen, R. and Baert, L. V.: Impalpable invisible state T1c prostate cancer: characteristics and clinical relevance in 100 radical prostatectomy specimens - a different view. J. Urol., 157: 244, 1997.
18. Partin, A. W., Kattan, M. W., Subong, E. N. P., Walsh, P. C., Wojno, K. J., Oesterling, J. E., Scardino, P T. and Pearson, J. D.: Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. J.A.M.A., 277: 1445, 1997.